Literature DB >> 15018924

Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodiesterase 5 inhibitors.

Weiqin Jiang1, Vernon C Alford, Yuhong Qiu, Sheela Bhattacharjee, T Matthew John, Donna Haynes-Johnson, Patricia J Kraft, Scott G Lundeen, Zhihua Sui.   

Abstract

The synthesis of the fused tetracyclic pyrroloquinolones 9a-i in four steps is described. The PDE5 inhibitory activities of these compounds, their selectivities against PDE1, PDE2, PDE3, PDE4 and PDE6, the preclinical pharmacokinetic assessments and the in vivo efficacy in increasing intracavernosal pressure are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018924     DOI: 10.1016/j.bmc.2003.12.044

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Traceless synthesis of diketopiperazine fused tetrahydro-β-carbolines on soluble polymer support.

Authors:  Kaushik Chanda; Cheng-Ting Chou; Jin-Ji Lai; Shu-Fen Lin; Gorakh S Yellol; Chung-Ming Sun
Journal:  Mol Divers       Date:  2010-10-10       Impact factor: 2.943

2.  Pharmacophore elucidation and molecular docking studies on phosphodiesterase-5 inhibitors.

Authors:  Awwad Abdoh Radwan
Journal:  Bioinformation       Date:  2015-02-28

3.  Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development.

Authors:  Gülru Kayık; Nurcan Ş Tüzün; Serdar Durdagi
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.